Suchergebnisse
Corteva Q2 Earnings Call Highlights
Key Points
- Interested in Corteva, Inc.? Here are five stocks we like better.
- Corteva raised its 2026 outlook after strong first-half results, now targeting operating EBITDA of $4.1 billion–$4.3
Wall Street Analysts Believe Nvidia (NVDA) Could Rally 56.03%: Here's is How to Trade
Nvidia (NVDA) closed the last trading session at $195.04, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe EuroDry (EDRY) Could Rally 30.65%: Here's is How to Trade
Shares of EuroDry (EDRY) have gained 15.5% over the past four weeks to close the last trading session at $25.51, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
How Much Upside is Left in Broadcom Inc. (AVGO)? Wall Street Analysts Think 33.73%
Broadcom Inc. (AVGO) closed the last trading session at $387.84, gaining 7.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 39.34% Upside in China Yuchai (CYD): Can the Stock Really Move This High?
China Yuchai (CYD) closed the last trading session at $48.32, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 26.95% Upside in Belden (BDC): Can the Stock Really Move This High?
Shares of Belden (BDC) have gained 1.5% over the past four weeks to close the last trading session at $117.11, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 185.99%: Read This Before Placing a Bet
Shares of Q32 Bio (QTTB) have gained 18.9% over the past four weeks to close the last trading session at $15.56, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 30.96% Upside in Celestica (CLS): Can the Stock Really Move This High?
Celestica (CLS) closed the last trading session at $352.59, gaining 4.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 41.62% Upside in XP Inc.A (XP): Can the Stock Really Move This High?
XP Inc.A (XP) closed the last trading session at $17.06, gaining 5.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know
Exponent (EXPO) closed the last trading session at $66.85, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Can Starbucks' Raised 2026 Outlook Drive a Durable Earnings Recovery?
Starbucks Corporation SBUX raised its fiscal 2026 outlook after stronger comparable sales and margin performance in the third quarter. The higher targets offer the clearest test yet of whether the
Kinross Q2 Earnings Call Centers on Costs and Project Execution
Kinross Gold Corporation KGC used its second-quarter 2026 earnings call to reinforce full-year targets while stressing project execution and cost discipline.
Adjusted earnings of $0.71 per share
Zalando Q2 Earnings Call Highlights
Zalando (ETR:ZAL) said its second-quarter results kept the company on track for its 2026 profit targets, although it narrowed its full-year growth outlook to the lower half of its prior range after
ConvaTec Group H1 Earnings Call Highlights
Key Points
- Interested in ConvaTec Group PLC? Here are five stocks we like better.
- ConvaTec maintained its 2026 targets after delivering 5% first-half organic revenue growth excluding
F&C Investment Trust Beats Benchmark, Targets 56th Straight Dividend Increase
Key Points
- Interested in F&C Investment Trust? Here are five stocks we like better.
- F&C Investment Trust delivered a 12.8% shareholder total return in the first half, slightly outperforming its
Can These 3 MedTech Stocks Hit Targets This Earnings Season?
The second-quarter 2026 earnings season is in full swing, with several MedTech companies already reporting results. According to the latest Earnings Preview, the Medical sector is likely to have
Does Nice (NICE) Have the Potential to Rally 26.25% as Wall Street Analysts Expect?
Nice (NICE) closed the last trading session at $100.65, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe PicS N.V. (PICS) Could Rally 54.69%: Here's is How to Trade
PicS N.V. (PICS) closed the last trading session at $12.8, gaining 12.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Thryv Q2 Earnings Call Highlights
Key Points
- Interested in Thryv Holdings, Inc.? Here are five stocks we like better.
- Thryv launched its AI-native Thryv Growth Platform on Aug. 3, targeting established local service businesses